In today’s briefing:
- ECM Weekly (2nd July 2023) – Tryt, J&T Express, Redox, Kelun, 4Paradigm, SIA, M&A Research, Walsin
ECM Weekly (2nd July 2023) – Tryt, J&T Express, Redox, Kelun, 4Paradigm, SIA, M&A Research, Walsin
- Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
- In the IPO space, Tryt Inc (9164 JP) will announce its price range in the coming week, while Kelun Biotech tries to break the US$100m+ deal silence in HK.
- On the placement front, even Singapore joined in the placement action this week, with only HK deal remaining absent over the past month.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
